Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • dinepat203 dinepat203 Apr 26, 2014 10:58 AM Flag

    MKT CAP IS $2BILLIONS!!!! BUT - SRPT IS SLEEPING-OCT2007 - JAN2013- ONLY 12 PATIENTS

    CLINICALTRIALS.GOV

    1 Completed Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (Eteplirsen)
    ClinicalTrials.gov Identifier: NCT01396239
    First received: July 8, 2011
    Last updated: January 22, 2013
    Enrollment: 12
    Study Start Date: July 2011
    Study Completion Date: June 2012
    Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)


    2 Active, not recruiting Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (Eteplirsen)
    Enrollment: 12
    Study Start Date: February 2012
    Estimated Study Completion Date: July 2015
    Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
    Enrollment: 19
    Study Start Date: January 2009
    Study Completion Date: December 2010
    Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)


    3 Completed Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 for Injection
    Enrollment: 19
    Study Start Date: January 2009
    Study Completion Date: December 2010
    Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)


    4 Completed Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

    Condition: Duchenne Muscular Dystrophy
    Intervention: Drug: AVI-4658 (PMO)
    Enrollment: 7
    Study Start Date: October 2007
    Study Completion Date: March 2009
    Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
26.78+1.02(+3.96%)Aug 26 4:00 PMEDT